The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
START: A phase III study of L-BLP25 cancer immunotherapy for unresectable stage III non-small cell lung cancer.
Charles Andrew Butts
Consultant or Advisory Role - Merck KGaA; Merck Serono
Honoraria - Merck KGaA; Merck Serono
Mark A. Socinski
Research Funding - EMD Serono
Paul Mitchell
Consultant or Advisory Role - Merck Serono
Research Funding - Merck Serono
Other Remuneration - Merck Serono
Nick Thatcher
Consultant or Advisory Role - Merck Serono
Honoraria - Merck Serono
Other Remuneration - Merck Serono
Libor Havel
No relevant relationships to disclose
Maciej Jerzy Krzakowski
No relevant relationships to disclose
Sergiusz Nawrocki
No relevant relationships to disclose
Tudor-Eliade Ciuleanu
No relevant relationships to disclose
Lionel Bosquée
No relevant relationships to disclose
Jose Manuel Trigo Perez
No relevant relationships to disclose
Alexander I. Spira
No relevant relationships to disclose
Lise Tremblay
No relevant relationships to disclose
Jan Nyman
Other Remuneration - Merck Serono
Rodryg Ramlau
No relevant relationships to disclose
Christoph Helwig
Employment or Leadership Position - Merck KGaA
Martin H. Falk
Employment or Leadership Position - Merck KGaA
Frances A. Shepherd
Consultant or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck; Recombio; Roche
Stock Ownership - Lilly; Pfizer
Honoraria - GlaxoSmithKline; Lilly; Roche
Expert Testimony - AstraZeneca